Paul Barclay

Paul Barclay

Company: Leo Pharma

Job title: Vice President, Global Program Head, Global Development


Closing Q&A Panel 5:40 pm

Read more

day: Day One

Updates on Non-Oral JAKi Therapy: Unique Challenges & Interest 9:00 am

Outlining current challenges and opportunities with alternative JAKi application Sharing insights from multidisciplinary backgrounds and application experience Speculating on the upcoming therapeutic landscape and potential for alternative JAKi interventionRead more

day: Day Two

Topical JAK Inhibitor Development – the Promise & the Challenges 4:50 pm

Exploring how efficacy compares with oral JAKs Recalling what methods are available to assess skin penetration and target occupancy Detailing whether lower systemic exposure leads to a better safety profile Sharing the regulatory challengesRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.